Literature DB >> 17439929

Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.

S C M S Fialho1, E Bonfá, L F Vitule, E D'Amico, V Caparbo, S Gualandro, R M R Pereira.   

Abstract

This study Identifies the possible risk factors for osteonecrosis (ON) in a homogenous group of early system lupus erythematosus (SLE). Forty-six consecutive SLE patients (<5 years duration) followed at the Lupus Clinic, were enrolled between 2004 and 2005. An extensive clinical and laboratory evaluation using a standard electronic protocol established since 1999, including osteonecrosis symptoms and appropriate magnetic resonance imaging (MRI), were carried out at 1-6 months intervals. All other asymptomatic for osteonecrosis patients at study entry underwent MRI. ON confirmed by MRI was found in 10 of 46 patients (22%). Age, disease duration, clinical vascular features, frequency of thrombophilia and hypofibrinolysis factors and the lipoprotein profile were comparable in patients with and without osteonecrosis (P > 0.05). Remarkably, the frequency of patients with system lupus erythematosus disease activity index (SLEDAI) > or =8 in the previous year of osteonecrosis clinical diagnosis was significantly higher when compared to patients without this manifestation (60.0% versus 19.4%, P = 0.011), supported by the higher glucocorticoid cumulative dose in the same period (P = 0.045). In contrast, these two parameters evaluated in 13th-24th months preceding osteonecrosis diagnosis were similar in patients with and without osteonecrosis (P > 0.05). In the logistic regression analysis only SLEDAI remained as an independent risk factor for ON (OR = 6.78, CI = 1.05-43.55, P = 0.04). Disease activity in the previous year of ON clinical diagnosis is the main predictor factor for the development of this complication in early SLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439929     DOI: 10.1177/0961203307076771

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  17 in total

1.  Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis.

Authors:  Kui Zhang; Yan Zheng; Junfeng Jia; Jin Ding; Zhenbiao Wu
Journal:  Clin Rheumatol       Date:  2017-09-25       Impact factor: 2.980

2.  The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  Kao-Kao Zhu; Wang-Dong Xu; Hai-Feng Pan; Min Zhang; Jing Ni; Fu-Yang Ge; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case-control study.

Authors:  Lidan Zhao; Xiuhua Wu; Honghua Wu; Jinmei Su; Wen Zhang; Yan Zhao; Xuan Zhang; Wenjie Zheng
Journal:  Rheumatol Int       Date:  2016-05-26       Impact factor: 2.631

4.  The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus.

Authors:  T C M Castro; H Lederman; M T A Terreri; W I Caldana; S C Kaste; M O Hilário
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

5.  Clinical profile of osteonecrosis in systemic lupus erythematosus - Experience from a tertiary care centre in South India.

Authors:  Saranya Chinnadurai; Balaji Chilukuri; Bhuvanesh Mahendran; Vignesh Mantharam; Balameena Selvakumar; Rajeswari Sankaralingam
Journal:  J Family Med Prim Care       Date:  2020-08-25

Review 6.  Multifocal osteonecrosis in systemic lupus erythematosus: case report and review of the literature.

Authors:  Luis D Fajardo-Hermosillo; Linnette López-López; Anaida Nadal; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2013-04-16

7.  Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus.

Authors:  Fumio Sekiya; Ken Yamaji; Kwangseok Yang; Hiroshi Tsuda; Yoshinari Takasaki
Journal:  Rheumatol Int       Date:  2009-10-07       Impact factor: 2.631

8.  Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.

Authors:  Young Bin Joo; Yoon-Kyoung Sung; Jee-Seon Shim; Jae-Hoon Kim; Eui-Kyung Lee; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2014-10-10       Impact factor: 2.631

9.  Association of common comorbidities with osteonecrosis: a nationwide population-based case-control study in Denmark.

Authors:  Alina Dima; Alma Becic Pedersen; Lars Pedersen; Cristian Baicus; Reimar Wernich Thomsen
Journal:  BMJ Open       Date:  2018-02-08       Impact factor: 2.692

10.  Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication.

Authors:  Paola Caramaschi; Domenico Biasi; Ilaria Dal Forno; Silvano Adami
Journal:  Autoimmune Dis       Date:  2012-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.